Literature DB >> 30192247

Preoperative Narcotic Use and Inferior Outcomes After Anatomic Total Shoulder Arthroplasty: A Clinical and Radiographic Analysis.

Kirk M Thompson1, Justin D Hallock, Richard A Smith, Tyler J Brolin, Frederick M Azar, Thomas W Throckmorton.   

Abstract

INTRODUCTION: Our purpose was to determine whether the chronic use of preoperative narcotics adversely affected clinical and/or radiographic outcomes.
METHODS: Seventy-three patients (79 shoulders) with primary total shoulder arthroplasty for osteoarthritis were evaluated clinically and radiographically at preoperative visits and postoperatively at a minimum follow-up of 2 years: 26 patients (28 shoulders) taking chronic narcotic pain medication for at least 3 months before surgery and 47 patients (51 shoulders) who were not taking narcotics preoperatively.
RESULTS: Postoperatively, significant differences were noted between the narcotic and nonnarcotic groups regarding American Shoulder and Elbow Surgeons scores and visual analog scale scores, as well as forward elevation, external rotation, and all strength measurements (P < 0.01). The nonnarcotic group had markedly higher American Shoulder and Elbow Surgeons scores, better overall range of motion and strength, and markedly lower visual analog scale scores than the narcotic group.
CONCLUSION: Chronic preoperative narcotic use seems to be a notable indicator of poor outcomes of anatomic total shoulder arthroplasty for glenohumeral osteoarthritis.

Entities:  

Mesh:

Substances:

Year:  2019        PMID: 30192247     DOI: 10.5435/JAAOS-D-16-00808

Source DB:  PubMed          Journal:  J Am Acad Orthop Surg        ISSN: 1067-151X            Impact factor:   3.020


  5 in total

1.  [Interpretation of 2020 American Academy of Orthopaedic Surgeons (AAOS) on the Management of Glenohumeral Joint Osteoarthritis Evidence-Based Clinical Practice Guideline].

Authors:  Xianxiang Xiang
Journal:  Zhongguo Xiu Fu Chong Jian Wai Ke Za Zhi       Date:  2021-11-15

2.  Prevalence of Prescription Opioids for Nonoperative Treatment of Rotator Cuff Disease Is High.

Authors:  Jacob Gorbaty; Susan M Odum; Meghan K Wally; Rachel B Seymour; Nady Hamid; Joseph R Hsu; Michael Beuhler; Michael J Bosse; Michael Gibbs; Christopher Griggs; Steven Jarrett; Daniel Leas; Tamar Roomian; Michael Runyon; Animita Saha; Bradley Watling; Stephen Wyatt; Ziqing Yu
Journal:  Arthrosc Sports Med Rehabil       Date:  2021-02-03

Review 3.  Clinical Outcomes Associated With Preoperative Opioid Use in Various Shoulder Surgical Procedures: A Systematic Review.

Authors:  Dan Michael J Devano; John-Rudolph Smith; Darby A Houck; Eric C McCarty; Adam J Seidl; Michelle L Wolcott; Rachel M Frank; Jonathan T Bravman
Journal:  Orthop J Sports Med       Date:  2021-04-21

4.  Application of risk assessment tools to predict opioid usage after shoulder surgery.

Authors:  Laila H Khoury; Josh Stephens; Shimron Brown; Kiran Chatha; Sarah Girshfeld; Juan Manuel Lozano Leon; Alessia Lavin; Vani J Sabesan
Journal:  JSES Int       Date:  2022-07-03

5.  Opioid use following a total shoulder arthroplasty: who requires refills and for how long?

Authors:  Corey C Spencer; Jeremiah A Pflederer; Jacob M Wilson; Alexander M Dawes; Michael B Gottschalk; Eric R Wagner
Journal:  JSES Int       Date:  2021-04-03
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.